Commercial Development: In August 2025, Jocasta Neuroscience raised $35 million in Series A funding to advance JN-0413, a proprietary -klotho formulation, through Phase 1 trials with IND submission planned for Q4 2026
The expected launch of Mazdutide will be the first domestic GLP-1 medicine with indications for both obesity and diabetes
Wegovy may harm an unborn baby, and you should stop using it at least 2 months before trying to conceive
Miamis humidity maintains skin moisture during healing, which is beneficial, but the heat and bacterial environment require extra care to prevent contamination of the treatment area during the first 72 hours
How long does it take for Zepbound to work
Because we operate in subspecialized units, we can tailor presurgical planning to the patients unique health needs, surgery type, and type of anesthesia